0,810  0,003  Mcl-1 antagonist
0,788  0,018  Apoptosis agonist
0,744  0,007  Mutagenic
0,650  0,011  Sensitization
0,608  0,013  12-Lipoxygenase inhibitor
0,548  0,015  Antioxidant
0,537  0,017  UGT1A9 substrate
0,536  0,018  CTGF expression inhibitor
0,533  0,016  Antifungal
0,548  0,032  15-Lipoxygenase inhibitor
0,525  0,011  Antineoplastic (non-Hodgkin's lymphoma)
0,537  0,024  Respiratory analeptic
0,519  0,007  Antineoplastic (small cell lung cancer)
0,543  0,032  Antileukemic
0,511  0,004  Antiviral (Influenza A)
0,509  0,005  Lipid peroxidase inhibitor
0,513  0,016  Antineoplastic (multiple myeloma)
0,525  0,032  CYP2C9 substrate
0,526  0,041  Transcription factor NF kappa B inhibitor
0,506  0,024  Cytotoxic
0,494  0,020  Chemopreventive
0,470  0,007  Contraceptive
0,474  0,012  Antihypoxic
0,481  0,024  FMO1 substrate
0,488  0,044  Antibacterial
0,461  0,021  Antiprotozoal (Leishmania)
0,465  0,029  CYP1A2 substrate
0,453  0,017  UGT1A6 substrate
0,449  0,020  UGT2B4 substrate
0,443  0,014  Pyruvate kinase inhibitor
0,436  0,012  Antineoplastic (bladder cancer)
0,454  0,030  Antineoplastic (melanoma)
0,427  0,008  Antiviral (Influenza)
0,463  0,048  CYP3A4 substrate
0,435  0,029  Lipoxygenase inhibitor
0,435  0,031  Analeptic
0,406  0,002  Bcl-xL inhibitor
0,408  0,005  Heat shock protein 90 alpha antagonist
0,474  0,071  Caspase 9 stimulant
0,408  0,014  Antiviral (HIV)
0,437  0,045  CYP2C19 inhibitor
0,391  0,004  Contraceptive female
0,386  0,004  Estrogen receptor alpha antagonist
0,406  0,031  Antineoplastic (non-small cell lung cancer)
0,373  0,005  Heat shock protein 90 antagonist
0,397  0,047  Aldehyde oxidase inhibitor
0,455  0,108  Antiinflammatory
0,367  0,021  Anesthetic general
0,423  0,081  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,365  0,030  Antiparasitic
0,420  0,094  Antineoplastic (solid tumors)
0,344  0,019  UGT2B7 substrate
0,322  0,005  Alcohol dehydrogenase substrate
0,319  0,003  Aldehyde dehydrogenase substrate
0,327  0,012  Neurotrophic factor enhancer
0,352  0,037  Antineoplastic (lymphoma)
0,326  0,016  Interferon gamma antagonist
0,315  0,009  UGT2B9 substrate
0,337  0,034  Nitric oxide antagonist
0,385  0,084  Antineoplastic (breast cancer)
0,373  0,072  Antineoplastic (lung cancer)
0,360  0,063  Prostate cancer treatment
0,304  0,013  Histone acetyltransferase inhibitor
0,313  0,022  Skin irritative effect
0,338  0,048  Antineoplastic (cervical cancer)
0,297  0,006  Contraceptive male
0,302  0,017  UGT2B15 substrate
0,320  0,037  Antineoplastic (lymphocytic leukemia)
0,316  0,038  DNA synthesis inhibitor
0,317  0,042  Carcinogenic
0,292  0,023  Melanin inhibitor
0,292  0,024  Antiseptic
0,283  0,022  Skin whitener
0,265  0,003  Bcl2 antagonist
0,349  0,087  Immunosuppressant
0,272  0,012  Antineoplastic antibiotic
0,280  0,020  Monophenol monooxygenase inhibitor
0,293  0,033  Antihelmintic
0,270  0,015  Antihyperlipoproteinemic
0,305  0,051  Free radical scavenger
0,316  0,065  Sodium/bile acid cotransporter inhibitor
0,312  0,064  Antineoplastic (pancreatic cancer)
0,342  0,096  Antiprotozoal
0,302  0,056  Antipyretic
0,261  0,016  Aldehyde dehydrogenase inhibitor
0,248  0,005  Aldose reductase inhibitor
0,307  0,066  Lipoprotein disorders treatment
0,277  0,037  RNA-directed DNA polymerase inhibitor
0,310  0,072  Antipsoriatic
0,302  0,066  CYP2C19 substrate
0,271  0,038  Hepatoprotectant
0,362  0,130  Alpha-glucosidase inhibitor
0,268  0,037  UGT1A4 substrate
0,237  0,007  HIV-1 integrase (Strand Transfer) inhibitor
0,326  0,098  Antineoplastic (myeloid leukemia)
0,291  0,064  Aryl hydrocarbon receptor agonist
0,256  0,029  Protein-tyrosine phosphatase inhibitor
0,233  0,007  NAD(P)H dehydrogenase (quinone) inhibitor
0,241  0,017  SULT1A3 substrate
0,229  0,007  TRPA1 agonist
0,302  0,081  Hepatic disorders treatment
0,231  0,010  Estrogen antagonist
0,224  0,004  Purinergic P2X2 antagonist
0,260  0,046  UDP-glucuronosyltransferase substrate
0,245  0,032  UGT1A3 substrate
0,263  0,050  Antihypertriglyceridemic
0,216  0,009  HIV-1 integrase (3'-Processing) inhibitor
0,294  0,086  AR expression inhibitor
0,265  0,061  Hypolipemic
0,297  0,093  Cholesterol antagonist
0,230  0,028  Acute respiratory distress syndrome (ARDS) treatment
0,249  0,047  UGT1A1 substrate
0,304  0,108  GST A substrate
0,213  0,018  Toll-Like receptor 2 antagonist
0,206  0,011  Porphobilinogen synthase inhibitor
0,216  0,023  Mannose-6-phosphate isomerase inhibitor
0,221  0,028  Genotoxic
0,262  0,070  Antineoplastic (glioma)
0,214  0,028  UGT2B10 substrate
0,333  0,146  DNA directed DNA polymerase inhibitor
0,202  0,017  Sulfotransferase substrate
0,280  0,097  Bone diseases treatment
0,329  0,150  DNA polymerase beta inhibitor
0,214  0,036  Phospholipase A2 inhibitor
0,212  0,035  Carcinogenic, group 3
0,213  0,037  Protein kinase stimulant
0,249  0,074  NOS2 expression inhibitor
0,219  0,049  Antipruritic, non-allergic
0,273  0,106  Apoptosis antagonist
0,235  0,068  Antineoplastic (glioblastoma multiforme)
0,258  0,092  Cardioprotectant
0,261  0,097  Antineoplastic (colorectal cancer)
0,250  0,091  Antiosteoporotic
0,186  0,026  Movement disorders treatment
0,206  0,048  3C-like protease (Human coronavirus) inhibitor
0,216  0,060  Pneumotoxic
0,170  0,015  Actinic keratosis treatment
0,156  0,004  Catechol O-methyltransferase inhibitor
0,236  0,085  Antihypercholesterolemic
0,253  0,102  NOS3 expression inhibitor
0,175  0,025  SULT1A1 substrate
0,246  0,097  Antineoplastic (colon cancer)
0,186  0,037  Antifungal enhancer
0,161  0,014  CYP2A6 inhibitor
0,152  0,005  SULT1A2 substrate
0,194  0,050  Acaricide
0,165  0,023  Papain-like protease (SARS coronavirus) inhibitor
0,191  0,051  Phospholipase C inhibitor
0,152  0,012  CDC25A inhibitor
0,144  0,007  5-Alpha-reductase inhibitor
0,237  0,100  Radioprotector
0,175  0,041  Toll-Like receptor antagonist
0,149  0,016  Estrogen receptor beta antagonist
0,167  0,039  Protein-tyrosine phosphatase 1B inhibitor
0,214  0,087  Cytostatic
0,260  0,134  Ulceration
0,182  0,057  Muscular dystrophy treatment
0,155  0,030  Mucolytic
0,224  0,100  Antiprotozoal (Trypanosoma)
0,142  0,018  Paget's disease treatment
0,168  0,045  Neurotrophic factor
0,155  0,033  Xanthine oxidase inhibitor
0,222  0,100  Proliferative diseases treatment
0,154  0,033  Ca2+-transporting ATPase inhibitor
0,220  0,100  DNA damaging
0,183  0,064  Succinate dehydrogenase inhibitor
0,236  0,120  GST M1-1 substrate
0,138  0,023  Aminoacyl-tRNA synthetase inhibitor
0,169  0,054  Aldose reductase substrate
0,199  0,087  Antineoplastic enhancer
0,129  0,020  Ornithine decarboxylase inhibitor
0,255  0,146  Calpain 2 inhibitor
0,139  0,031  Beta glucuronidase inhibitor
0,133  0,024  UGT2B11 substrate
0,148  0,040  Carcinogenic, group 2B
0,141  0,033  UGT2B1 substrate
0,117  0,011  CDC25B inhibitor
0,164  0,058  Antidiarrheal
0,120  0,015  HIV-1 integrase inhibitor
0,216  0,111  Antineoplastic (ovarian cancer)
0,172  0,068  Aldehyde oxidase substrate
0,204  0,104  Antineoplastic (liver cancer)
0,148  0,050  Topoisomerase II inhibitor
0,165  0,068  Eye irritation, high
0,165  0,071  Arachidonic acid antagonist
0,123  0,029  Topoisomerase II alpha inhibitor
0,149  0,056  Alpha-N-acetylglucosaminidase inhibitor
0,184  0,091  Insulin sensitizer
0,124  0,032  Alcohol dehydrogenase inhibitor
0,118  0,027  Xanthine oxidase substrate
0,133  0,043  Expectorant
0,100  0,013  Antimycoplasmal
0,197  0,110  Antihypotensive
0,135  0,049  Sphingosine 1-phosphate receptor 4 antagonist
0,249  0,164  Antipruritic, allergic
0,109  0,025  Granulocyte macrophage colony stimulating factor agonist
0,113  0,029  Antibiotic
0,212  0,131  5 Hydroxytryptamine uptake stimulant
0,120  0,039  Anabolic
0,092  0,012  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,145  0,068  Antineoplastic (squamous cell carcinoma)
0,205  0,128  Chemoprotective
0,130  0,060  Coagulant
0,100  0,031  Phosphofructokinase-1 inhibitor
0,158  0,089  ATPase inhibitor
0,086  0,018  Alpha tubulin antagonist
0,163  0,099  Antirickettsial
0,095  0,031  Estrogen-related receptor beta agonist
0,073  0,011  Pregnane X receptor antagonist
0,120  0,060  Transcription factor STAT6 inhibitor
0,195  0,136  Streptokinase A inhibitor
0,115  0,055  Gout treatment
0,128  0,069  Vanilloid 1 agonist
0,118  0,060  Photosensitizer
0,085  0,028  Anticholelithogenic
0,099  0,042  ATPase (Vacuolar H+) inhibitor
0,102  0,045  Androgen antagonist
0,112  0,056  Antiviral (Coronavirus)
0,112  0,056  Antiviral (SARS coronavirus)
0,164  0,108  CYP2B6 inhibitor
0,111  0,057  HDL-cholesterol increasing
0,086  0,032  Glycine receptor agonist
0,077  0,027  Purinergic P2X1 antagonist
0,195  0,145  Radiosensitizer
0,113  0,063  Cystathionine beta-synthase inhibitor
0,125  0,077  Anesthetic
0,080  0,033  Peroxisome proliferator-activated receptor gamma antagonist
0,086  0,040  Glutamate dehydrogenase inhibitor
0,088  0,043  Na+ K+ transporting ATPase inhibitor
0,085  0,041  GABA aminotransferase inhibitor
0,067  0,023  Dihydroorotate dehydrogenase inhibitor
0,069  0,026  Botulinum neurotoxin type A inhibitor
0,074  0,031  Aromatase inhibitor
0,106  0,064  DOPA decarboxylase inhibitor
0,217  0,175  Antiprotozoal (Plasmodium)
0,056  0,015  Retinoid X receptor agonist
0,189  0,149  Flavin-containing monooxygenase substrate
0,191  0,152  Tyrosine 3 hydroxylase inhibitor
0,061  0,021  CD45 antagonist
0,120  0,081  Antibacterial (Helicobacter pylori)
0,051  0,012  Retinoid X receptor antagonist
0,102  0,063  5-Lipoxygenase inhibitor
0,165  0,126  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,113  0,075  Alkylator
0,093  0,055  Triose-phosphate isomerase inhibitor
0,051  0,016  Alpha 1L adrenoreceptor agonist
0,048  0,016  Inosine monophosphate dehydrogenase inhibitor
0,043  0,011  Retinoid X alpha receptor antagonist
0,047  0,015  Retinoid X alpha receptor agonist
0,043  0,012  HMG CoA reductase inhibitor
0,174  0,143  Calpain inhibitor
0,092  0,062  Uric acid excretion stimulant
0,055  0,026  Squalene epoxidase inhibitor
0,110  0,081  Antiviral (Hepatitis B)
0,168  0,141  Myocardial infarction treatment
0,135  0,111  Carcinogenic, group 1
0,166  0,142  Immunostimulant
0,199  0,175  ICAM1 expression inhibitor
0,075  0,054  Antitreponemal
0,062  0,041  Heme oxygenase stimulant
0,055  0,034  Acetyl-CoA transferase inhibitor
0,091  0,071  UDP-glucose 4-epimerase inhibitor
0,189  0,171  Thyroid hormone antagonist
0,024  0,008  Retinoid X beta receptor antagonist
0,061  0,045  Corticotropin releasing factor 2 receptor antagonist
0,058  0,043  Heat shock protein 90 beta antagonist
0,083  0,069  Antidote, mercury
0,051  0,037  Glucose-6-phosphate translocase inhibitor
0,028  0,016  Retinoid X gamma receptor antagonist
0,213  0,201  Antineoplastic (endocrine cancer)
0,110  0,099  Alkaline phosphatase inhibitor
0,019  0,008  Thyroid hormone alpha agonist
0,041  0,030  Estradiol 17 beta-dehydrogenase inhibitor
0,085  0,075  Glutamate release inhibitor
0,032  0,023  Glutamate (mGluR3) agonist
0,089  0,081  Topoisomerase I inhibitor
0,128  0,120  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,092  0,085  Choleretic
0,079  0,072  3C-Like protease (SARS coronavirus) inhibitor
0,159  0,153  VCAM1 expression inhibitor
0,082  0,076  HIV-1 integrase (Overall Integration) inhibitor
0,118  0,113  Antiviral (Herpes)
0,030  0,025  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,178  0,176  Thyroid hormone beta antagonist
0,019  0,018  Estrone sulfatase inhibitor
0,172  0,172  CYP2D6 substrate
0,024  0,023  Thyroid hormone agonist
0,019  0,019  Estradiol 17 beta-dehydrogenase 1 inhibitor

